<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>38(3)</volume><submitter>Pacheva M</submitter><funding>Stiftung für Kleintiere der Vetsuisse-Fakultät Universität Zürich</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Corticosteroids are among the most commonly used drugs in cats and are increasingly discussed as a treatment for feline pancreatitis. However, its effects on serum lipase in healthy cats remain unknown.&lt;h4>Objectives&lt;/h4>To evaluate the effects of prednisolone on serum lipase activity and pancreatic lipase immunoreactivity (PLI) in cats.&lt;h4>Animals&lt;/h4>Seven clinically healthy colony cats, aged 4 to 7 years, with unremarkable CBC/biochemistry panel were studied.&lt;h4>Methods&lt;/h4>Prospective study: Prednisolone (1.1-1.5 mg/kg, median 1.28 mg/kg PO) was given daily for 7 consecutive days. Lipase activity (LIPC Roche; RI, 8-26 U/L) and PLI (Spec fPL; RI, 0-3.5 μg/L) were determined at day 1 before first treatment and at days 2, 3, 8, 10, and 14. Cats were examined daily. An a</pubmed_abstract><journal>Journal of veterinary internal medicine</journal><pagination>1370-1376</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11099763</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effects of prednisolone on 1,2-O-dilauryl-rac-glycero glutaric acid-(60-methylresorufin) ester-lipase activity and pancreatic lipase immunoreactivity in healthy cats.</pubmed_title><pmcid>PMC11099763</pmcid><pubmed_authors>Kook PH</pubmed_authors><pubmed_authors>Brugger D</pubmed_authors><pubmed_authors>Riond B</pubmed_authors><pubmed_authors>Pacheva M</pubmed_authors><pubmed_authors>Dennler M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of prednisolone on 1,2-O-dilauryl-rac-glycero glutaric acid-(60-methylresorufin) ester-lipase activity and pancreatic lipase immunoreactivity in healthy cats.</name><description>&lt;h4>Background&lt;/h4>Corticosteroids are among the most commonly used drugs in cats and are increasingly discussed as a treatment for feline pancreatitis. However, its effects on serum lipase in healthy cats remain unknown.&lt;h4>Objectives&lt;/h4>To evaluate the effects of prednisolone on serum lipase activity and pancreatic lipase immunoreactivity (PLI) in cats.&lt;h4>Animals&lt;/h4>Seven clinically healthy colony cats, aged 4 to 7 years, with unremarkable CBC/biochemistry panel were studied.&lt;h4>Methods&lt;/h4>Prospective study: Prednisolone (1.1-1.5 mg/kg, median 1.28 mg/kg PO) was given daily for 7 consecutive days. Lipase activity (LIPC Roche; RI, 8-26 U/L) and PLI (Spec fPL; RI, 0-3.5 μg/L) were determined at day 1 before first treatment and at days 2, 3, 8, 10, and 14. Cats were examined daily. An a</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May-Jun</publication><modification>2026-06-27T03:16:27.576Z</modification><creation>2026-06-27T03:05:02.856Z</creation></dates><accession>S-EPMC11099763</accession><cross_references><pubmed>38485220</pubmed><doi>10.1111/jvim.17042</doi></cross_references></HashMap>